G. Livni et al., INCIDENCE AND SEVERITY OF GROUP-A STREPTOCOCCAL BACTEREMIA IN A MEDICAL-CENTER IN ISRAEL, 1981-1994, Scandinavian journal of infectious diseases, 28(2), 1996, pp. 139-142
To determine recent trends in the incidence and severity, group A stre
ptococcal (GAS) bacteremia was studied over the last 14 Sears (1981-19
94). There were 116 events of GAS bacteremia, representing 1.7% of all
bacteremic episodes, without an increase in recent years. A total of
108 patients were available for study. Underlying conditions were foun
d in 95 patients (88%), including mainly malignant diseases, chronic o
bstructive pulmonary disease, congestive heart failure and diabetes me
llitus. A source of the bacteremia was noted in 71 patients (66%), wit
h skin and soft tissue infection being the major portal of entry. All
isolates were susceptible to penicillin. Overall mortality was 21%. Mo
rtality had not increased in recent years, but depended significantly
on several clinical factors: increased age; admission temperature; sou
rce of bacteremia (highest for GAS bacteremia without an identified so
urce); and underlying conditions (highest for diabetes mellitus and ch
ronic pulmonary disease, absent for patients with no underlying diseas
e). This study shows that neither the incidence nor the severity of GA
S bacteremia has increased in recent years, Severity is significantly
affected by the source of bacteremia and the presence of underlying co
nditions.